Skip to content

Clinical trial of cutaneous vasculitis

CLINICO PATHOLOGICAL STUDY OF CUTANEOUS VASCULITIS AND ITS IMMUNOLOGICAL CORRELATION

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/048532
Enrollment
50
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L959- Vasculitis limited to the skin, unspecified

Interventions

None listed

Sponsors

Indian association of dermatologist venereologist and leprologist
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All Patients ( New or Referral from other specialities) having cutaneous findings suggestive of cutaneous vasculitis 2. Patient willing to give informed consent for enrolment

Exclusion criteria

Exclusion criteria: 1.Patients previously diagnosed and on treatment for cutaneous vasculitis 2.Any non immunological petechial rash (a) patients with thrombocytopenia (less than 50000/mm3) (b) patients with disorder of coagulation (c) patients on anticoagulants 3.Patients not willing to give consent for enrolment

Design outcomes

Primary

MeasureTime frame
To study the clinical presentation of cutaneous vasculitis and establish a histopathological and Immunological correlation along with Direct Immuno Fluorescence findingsTimepoint: It is a cross sectional single visit study on day 0.

Secondary

MeasureTime frame
Early diagnosis of any associated serious underlying multi-system involvement can be done via a thorough correlation of clinical history, along with histopathological evidence and immunological findings.Timepoint: It is a cross sectional single visit study on day 0

Countries

India

Contacts

Public ContactDr Pooja Agarwal

Smt NHL Municipal Medical College, Ahmedabad

pooja.kgmc@gmail.com9426671569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026